TNXP – tonix pharmaceuticals holding corp. (US:NASDAQ)
Stock Stats
News
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit
Tonix Pharmaceuticals (NASDAQ:TNXP) was upgraded by analysts at Wall Str
Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026
Tonix Pharmaceuticals (NASDAQ:TNXP) was downgraded by analysts at Wall S
Tonix prices 615,025 shares at $16.26 in registered direct offering [Yahoo! Finance]
Form 5 Tonix Pharmaceuticals For: Dec 31 Filed by: SAENGER BRADLEY
Form 8-K Tonix Pharmaceuticals For: Feb 03
Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: VANGUARD GROUP INC
Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: BlackRock, Inc.
Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: Point72 Asset Management, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.